High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
Authors
Keywords
Colorectal cancer, Microsatellite instability, Lynch syndrome, Biomarkers, Conventional chemotherapy, Targeted therapy
Journal
Familial Cancer
Volume 15, Issue 3, Pages 405-412
Publisher
Springer Nature
Online
2016-02-13
DOI
10.1007/s10689-016-9884-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microsatellite instability: an update
- (2015) Hiroyuki Yamamoto et al. ARCHIVES OF TOXICOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
- (2015) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice
- (2015) Joan Maurel et al. CURRENT CANCER DRUG TARGETS
- PD-1/PD-L1 inhibitors
- (2015) Joel Sunshine et al. CURRENT OPINION IN PHARMACOLOGY
- Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers
- (2015) Ida Marie Heeholm Sønderstrup et al. Molecular Oncology
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antagonists of PD-1 and PD-L1 in Cancer Treatment
- (2015) Evan J. Lipson et al. SEMINARS IN ONCOLOGY
- Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer
- (2015) Filippo Pietrantonio et al. Targeted Oncology
- Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review
- (2015) Yanliang Li et al. TUMOR BIOLOGY
- Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis
- (2015) Chen-guo Zheng et al. TUMOR BIOLOGY
- Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
- (2015) Elena Maccaroni et al. Oncotarget
- Anti program death-1/anti program death-ligand 1 in digestive cancers
- (2015) Eléonore de Guillebon World Journal of Gastrointestinal Oncology
- Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
- (2014) Z. Gatalica et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
- (2014) Fabio Coppedè WORLD JOURNAL OF GASTROENTEROLOGY
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Unleashing the immune system: PD-1 and PD-Ls in the pre-treatment tumor microenvironment and correlation with response to PD-1/PD-L1 blockade
- (2014) Janis M Taube OncoImmunology
- Role of MGMT as biomarker in colorectal cancer
- (2014) Alessandro Inno World Journal of Clinical Cases
- Decoding the Histone Code: Role of H3K36me3 in Mismatch Repair and Implications for Cancer Susceptibility and Therapy
- (2013) G.-M. Li CANCER RESEARCH
- The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
- (2013) Feng Li et al. CELL
- Chemotherapy of MMR-deficient colorectal cancer
- (2013) N. Devaud et al. Familial Cancer
- Correlation of tumour BRAF mutations andMLH1methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification
- (2012) Michael T Parsons et al. JOURNAL OF MEDICAL GENETICS
- Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
- (2012) William K. Funkhouser et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?
- (2011) Einat Shacham-Shmueli et al. JOURNAL OF CLINICAL ONCOLOGY
- TOP1gene copy numbers in colorectal cancer samples and cell lines and their association toin vitrodrug sensitivity
- (2011) Maria Unni Rømer et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Mismatch repair deficient colorectal cancer in the era of personalized treatment
- (2010) Madeleine Hewish et al. Nature Reviews Clinical Oncology
- Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer
- (2010) Victoria Gonzalo et al. PLoS One
- Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis
- (2010) Bernd Timmermann et al. PLoS One
- Modulation of mismatch repair and genomic stability by miR-155
- (2010) N. Valeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression
- (2009) Søren A Jensen et al. BMC CANCER
- Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study
- (2009) Miriam Koopman et al. EUROPEAN JOURNAL OF CANCER
- Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
- (2009) Gaëtan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- Thymidylate synthase and microsatellite instability in colorectal cancer: Implications for disease free survival, treatment response and survival with metastases
- (2008) R. Bendardaf et al. ACTA ONCOLOGICA
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
- (2008) Leigha Senter et al. GASTROENTEROLOGY
- Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
- (2008) Marjolijn J L Ligtenberg et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started